The global
healthcare marketplace continues to undergo major transition. Many
of the new technologies driving change will transform markets and
redefine product categories. Novel diagnostics allows disease risk
assessment, earlier disease detection, supports individual therapy
selection and the monitoring of therapy efficacy. Therapies of the
future will be more personalised targeting specific sub-segments.
The Internet continues to drive new business models with far
reaching implications for transforming healthcare delivery. Sales
forces will increasingly use web-based methods for getting their
message across to doctors and patients. In addition to technology
driven changes the market is also driven by demographic and social
changes. Ageing populations in the developed world is leading to
increases in age-related diseases such as cardiovascular and cancer.
The advent of managed care type systems in the national healthcare
delivery of many countries are aimed at improving the efficiency of
healthcare whilst reducing cost. Geographically India and China are
emerging as key players and markets. Biotech and pharmaceutical
companies are also under pressure to increase the rate of drug
discovery and shortening the time to market. This reduction in time
frames and increases in the number of product launches throw up
regulatory hurdles and marketing challenges. Companies have to
respond to this competitive environment by considered product
positioning to achieve differentiation, accelerated clinical
development and regulatory approvals, minimise time to market and
achieve launch in multiple markets quickly.

JasTech has a
wealth of international experience in this marketplace and is well
positioned to assist clients in successfully meeting the challenges
posed through the development and implementation of tailored
solutions. Our package of marketing services includes: